Serge Saxonov - 22 Aug 2023 Form 4 Insider Report for 10x Genomics, Inc. (TXG)

Role
Chief Executive Officer, Director
Signature
/s/ Eric S. Whitaker, as Attorney-in-Fact for Serge Saxonov
Issuer symbol
TXG
Transactions as of
22 Aug 2023
Net transactions value
-$172,000
Form type
4
Filing time
24 Aug 2023, 18:11:19 UTC
Previous filing
16 Aug 2023
Next filing
18 Sep 2023
SEC
View on sec.gov

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction TXG Class A Common Stock Sale $172,000 -3,757 -0.43% $45.78 864,093 22 Aug 2023 Direct F1
holding TXG Class A Common Stock 27 22 Aug 2023 See footnote F2
holding TXG Class A Common Stock 870 22 Aug 2023 See footnote F3
holding TXG Class A Common Stock 183,350 22 Aug 2023 See footnote F4
holding TXG Class A Common Stock 16,320 22 Aug 2023 See footnote F5
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 The shares were sold to cover tax withholding obligations in connection with the vesting of restricted stock units.
F2 The shares are held by the Andromeda Trust, for which the Reporting Person serves as trustee.
F3 The shares are held by the Sirius Trust, for which the Reporting Person serves as trustee.
F4 The shares are held by the Y/S Descendants' Trust, for which the Reporting Person serves as trustee.
F5 The shares are held by the Y/S Pot Trust, for which the Reporting Person serves as trustee.